23/01/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

23/01/2025

Jan 23, 2025, 02:32 | Blog
Rob Winn: Eliminating the cancer burden and ensuring that the miracle medicine reaches every community
Rob Winn, Director and Lipman Chair in Oncology at VCU Massey Comprehensive Cancer Center, shared…
Jan 23, 2025, 02:32 | Blog
Children's Cancer Institute - Cancer Australia consulted on the Draft National Framework for Genomics in Cancer Control
Children's Cancer Institute shared a post on LinkedIn: "Cancer Australia recently consulted on the Draft…
Jan 23, 2025, 02:32 | Blog
Bruce Dunbar: Lung cancer is still the number 1 cancer killer
Bruce Dunbar, Patient and Research Advocate, shared a post by Balazs Halmos Associate Director for…
Jan 23, 2025, 02:32 | Blog
Shaun Lintern: Thousands of NHS patients have died, gone blind or suffered serious injuries because of delays in their care
Shaun Lintern, Health Editor, The Sunday Times, shared a post on LinkedIn: "EXCLUSIVE: Thousands of…
Jan 23, 2025, 02:32 | Blog
Susan Galbraith: 5 key trends that have the potential to transform cancer care
Susan Galbraith, Executive Vice President in Oncology R&D at AstraZeneca, shared a post on LinkedIn:…
Jan 23, 2025, 02:32 | Blog
Christian Ntizimira: It is not the living who close the eyes of the dying, but the dying who open the eyes of the living
Christian Ntizimira, Executive Director of ACREOL, shared a post on LinkedIn: "A big thank you…
Jan 23, 2025, 02:32 | Blog
Manoj Reddy: Honoring the legacy of Dr. Martin Luther King Jr.
Manoj Reddy, Founder and President of IOWG, shared a post on LinkedIn: "Today, as we…
Jan 23, 2025, 02:32 | Blog
Muhammad Umair Mushtaq: Successful Use of a Midline Catheter for Leukapheresis in Immune Effector Cell Therapy
Muhammad Umair Mushtaq, Associate Professor of Medicine at the University of Kansas Medical Center, shared…
Jan 23, 2025, 02:32 | Blog
The safety and effectiveness of sacituzumab govitecan with trastuzumab for HER2+ Metastatic Breast Cancer
Dana-Farber’s Breast Oncology Center shared on X: "The SATEENtrial led by Dana-Farber’s Breast Oncology Center…
Jan 23, 2025, 02:31 | Blog
Laura Bukavina: 8 doses of BCG vs. no treatment in high grade T1 bladder cancer
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X: "JCOG1019 trial…
All: 120 Posts: 111 - 120
Special Coverage